Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials | CNN

Singapore News News

Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials | CNN
Singapore Latest News,Singapore Headlines
  • 📰 cnni
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 59%

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said

Monday. Gantenerumab is part of a class of injected drugs that are designed to remove sticky protein pieces called beta amyloid from the brain. Beta amyloid buildup is a hallmark of Alzheimer’s disease. Most of these drugs have worked as intended to clear the beta amyloid, but many have still failed to demonstrate any real-life benefits to patients; their brain function and memory doesn’t improve significantly, despite treatment.

The results for gantenerumab follow positive results for a different beta amyloid reducing drug, lecanemab. The companies testing that medication, Biogen and Eisai, announced this year that lecanemab had slowed the decline of brain function in Alzheimer’s disease by about 27% compared with a placebo.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

cnni /  🏆 326. in US

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CIA Director Bill Burns meeting with Russian counterpart Monday | CNN PoliticsCIA Director Bill Burns meeting with Russian counterpart Monday | CNN PoliticsCIA Director Bill Burns is meeting with his Russian intelligence counterpart, Sergey Naryshkin, in Ankara Monday as part of an ongoing effort by the US to 'communicate with Russia on managing risk' and to discuss the cases of 'unjustly detained US citizens,' a National Security Council spokesperson tells CNN.
Read more »

Video: Is 'quiet quitting' over on CNN Nightcap | CNN BusinessVideo: Is 'quiet quitting' over on CNN Nightcap | CNN BusinessInsider's senior correspondent Aki Ito tells 'Nightcap's' Jon Sarlin why a recruiter who embraced 'quiet quitting' is now back to working 50 hours a week and why 'quiet quitters' may now be losing their bargaining power at work. For more, watch the full Nightcap episode here.
Read more »

USAF's experimental space plane home after record flight | Digital TrendsUSAF's experimental space plane home after record flight | Digital TrendsThe Air Force’s experimental X37B spaceplane has returned to Earth after a record mission lasting 908 days, beating its previous stay in space by 129 days.
Read more »

Why Doctors Are Intrigued By Experimental High Blood Pressure Medication BaxdrostatWhy Doctors Are Intrigued By Experimental High Blood Pressure Medication BaxdrostatPeople on the medication saw an impressive blood pressure drop of 20 points in a clinical trial.
Read more »

Experimental Alzheimer's drug fails to slow cognitive decline in clinical trialsExperimental Alzheimer's drug fails to slow cognitive decline in clinical trialsAn experimental Alzheimer's drug failed to slow cognitive decline in a long-awaited trial, marking the latest disappointment in a research field that has been wrought with setbacks.
Read more »

Suns update: Chris Paul (heel) questionable, Landry Shamet (concussion) out Monday at MiamiSuns update: Chris Paul (heel) questionable, Landry Shamet (concussion) out Monday at MiamiPhoenix Suns point guard Chris Paul is listed as questionable and guard Landry Shamet (concussion protocol) is ruled out Monday's game at Miami.
Read more »



Render Time: 2025-03-06 14:10:37